» Articles » PMID: 36300215

Oral Glucose Tolerance Test: Ηow to Maximize Its Diagnostic Value in Children and Adolescents

Overview
Journal Acta Biomed
Specialty General Medicine
Date 2022 Oct 27
PMID 36300215
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recently, the validity of the oral glucose tolerance test (OGTT) as a gold-standard test for the diagnosis of glucose dysregulation (GD) has been questioned due to the pre-analytical, analytical, and post-analytical variables which can potentially affect its reproducibility and accuracy.

Aims: In this short update, the many  variables that affect the reproducibility and accuracy of the OGTT are described and discussed aiming to enhance its diagnostic value  in  clinical practice.

Search Strategy: A systematic search was implemented in June 2022, using Scopus, PubMed, Embase and Google Scholar focusing on OGTT relevant  papers published in the last 10 years. Moreover,  the reference lists of these  articles were checked for additional pertinent studies. The research and selection of articles was also supported by the long-term authors' experience in the use of OGTT for the diagnosis of GD in children and adolescents.

Conclusion: The complexity of diagnosing GD presupposes that clinicians have specific knowledge and experience to perform rigorous assessment of glucose metabolism. It is worth mentioning that during OGTT, subjects with glucose levels  close to the cut-off values proposed  by WHO (World Health Organization)/ADA (American Diabetes Association) require careful evaluation in order to avoid misclassification and unnecessary interventions. For this reason, ADA recommends a second test to confirm the diagnosis of diabetes.

Citing Articles

A Multicenter ICET-A Survey on Adherence to Annual Oral Glucose Tolerance Test (OGTT) Screening in Transfusion-Dependent Thalassemia (TDT) Patients - The Expert Clinicians' Opinion on Factors Influencing the Adherence and on Alternative Strategies....

De Sanctis V, Canatan D, Daar S, Kattamis C, Banchev A, Modeva I Mediterr J Hematol Infect Dis. 2025; 17(1):e2025008.

PMID: 39830799 PMC: 11740908. DOI: 10.4084/MJHID.2025.008.


Cardiometabolic Risk Assessment in a Cohort of Children and Adolescents Diagnosed with Hyperinsulinemia.

Sodero G, Rigante D, Pane L, Sessa L, Quarta L, Candelli M Diseases. 2024; 12(6).

PMID: 38920551 PMC: 11202913. DOI: 10.3390/diseases12060119.


Prediabetes in children and adolescents: An updated review.

Ng H, Chan L World J Clin Pediatr. 2024; 12(5):263-272.

PMID: 38178932 PMC: 10762598. DOI: 10.5409/wjcp.v12.i5.263.


A prospective guide for clinical implementation of selected OGTT- derived surrogate indices for the evaluation of β- cell function and insulin sensitivity in patients with transfusion-dependent β- thalassaemia.

De Sanctis V, Soliman A, Daar S, Tzoulis P, Karimi M, Saki F Acta Biomed. 2023; 94(6):e2023221.

PMID: 38054665 PMC: 10734222. DOI: 10.23750/abm.v94i6.15329.


Characteristics of Children and Adolescents with Hyperinsulinemia Undergoing Oral Glucose Tolerance Test: A Single-Center Retrospective Observational Study.

Cipolla C, Lazzareschi I, Curatola A, Lasorella C, Pane L, Sessa L Diseases. 2023; 11(3).

PMID: 37754306 PMC: 10530243. DOI: 10.3390/diseases11030110.


References
1.
Trico D, Galderisi A, Mari A, Santoro N, Caprio S . One-hour post-load plasma glucose predicts progression to prediabetes in a multi-ethnic cohort of obese youths. Diabetes Obes Metab. 2019; 21(5):1191-1198. PMC: 6459710. DOI: 10.1111/dom.13640. View

2.
Kasturi K, Onuzuruike A, Kunnam S, Shomaker L, Yanovski J, Chung S . Two- vs one-hour glucose tolerance testing: Predicting prediabetes in adolescent girls with obesity. Pediatr Diabetes. 2018; 20(2):154-159. PMC: 6361688. DOI: 10.1111/pedi.12803. View

3.
Qiao Q, Lindstrom J, Valle T, Tuomilehto J . Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia. Diabet Med. 2003; 20(12):1027-33. DOI: 10.1111/j.1464-5491.2003.01054.x. View

4.
Chan A, Swaminathan R, Cockram C . Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem. 1989; 35(2):315-7. View

5.
De Sanctis V, Daar S, Soliman A, Tzoulis P, Karimi M, Di Maio S . Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience. Acta Biomed. 2022; 93(1):e2022158. PMC: 8972848. DOI: 10.23750/abm.v93i1.12802. View